Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5

Molecular Psychiatry

Volumn 4, Issue 6, 1999, Pages 558-565

  Kirov, G ^a   Jones, I ^b   McCandless, F ^b   Craddock, N ^b   Owen, M J ^a  

^a Tenovus Building   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Dopamine receptors; TDT

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER;

ADULT; ARTICLE; DNA POLYMORPHISM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NEUROTRANSMISSION; PENETRANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032739389     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000565     Document Type: Article

References (62)

1. 1 Tsuang MT, Faraone SV. The Genetics of Mood Disorders. John Hopkins University Press: Baltimore, 1990.
2. 2 McGuffin P, Owen MJ, O'Donovan MG, Thapar A, Gottesman IL Affective disorders. Seminars in Psychiatric Genetics. Royal College of Psychiatrists, 1994, pp 110-127.
3. 3 Craddock N, Khodel V, Van Eerdewogh P, Reich T. Mathematical limits of multilocus models: the genetic transmission of bipolar disorder. Am J Hum Genet 1995; 57: 690-702.
4. 4 Owen MJ, McGuffin P. Association and linkage: complementary strategies for complex disorders. J Med Genet 1993; 30; 638-639.
5. 5 Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
6. 6 Murphy DL, Brodie HK. Goodwill FK, Bunney WE. Regular induction of hypomania by L-DOPA in 'bipolar' manic-depressive patients. Nature 1971; 229: 135-136.
7. 7 Goodwill FK, Jamison KR. Manic-depressive Illness. Oxford University Press: New York, 1990.
8. 8 Diehl D, Gershon S. The role of dopamine in mood disorders. Compr Psychiatry 1992; 2: 115-120.
9. 9 Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: the Fourth Generation of Progress. Raven Press: New York, 1995, pp 921-931.
10. 10 Brown AS, Gershon S. Dopamine and depression. J Neurol Transm, Genet Sec 1993; 91: 75-109.
11. 11 Bonhomme N, Esposito E. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J Clin Psychopharmacol 1998; 18: 447-454.
12. 12 Nierenberg AA, Dougherty D, Rosenbaum JF. Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry 1998; 59 Suppl 5: 60-63.
13. 13 Jaber M, Jones S, Giros B, Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Movement Disord 1997; 12: 629-633.
14. 14 Vandenbergh DJ, Persico AM, Hawkins AL, Griflin CA, Li X, Jabs EW et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 und displays a VNTR. Genomics 1992; 14: 1104-1106.
15. 15 Kobayashi K, Kiuchi K, Ishii A, Kaneda N, Kurosawa Y, Fujita K et al. Human dopamine β-hydroxylase gene: two mRNA types having different 3-terminal regions are produced through alternative polyadenylation. Nucl Acids Res 1989; 17: 1089-1102.
16. 16 Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F et al. Population genetics of a functional variant of the dopamine β-hydroxylase gene (DBH). Am J Med Genet 1997; 74: 374-379.
17. 17 Axelrod J, Tomchick R. Enzymatic O-methylation of epineplirine and other catechols. J Biol Chem 1958; 233: 703-705.
18. 18 Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, Weinshilboum RM. Human catehol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
19. 19 Sunhara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G et al. Cloning of the gene for human D5 receptor with higher affinity for dopamine than D1. Nature 1991; 350: 614-619.
20. 20 Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. JAMA 1994; 271: 204-208.
21. 21 Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997; 6: 577-582.
22. 22 Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 1998; 3: 141-149.
23. 23 Lundstrom K, Turpin MP, Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki forest virus system. Biochem Biophys Res Comm 1996; 225: 1068-1072.
24. 24 Blackwood DHR, He L, Morris SW, McLean A, Whitton G, Thornson M et al. A locus for bipolar affective disorder on chromosome 4p. Nature Genet 1996; 12: 427-430.
25. 25 Asherson P, Mant R, Williams N, Cardno A. Jones L, Murphy K et al. A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mol Psychiatry 1998; 3: 310-320.
26. 26 Sherrington R, Mankoo B, Attwood J, Kalsi G, Curtis D, Buetow K et al. Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite For the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1. Genomics 1993; 18: 423-425.
27. 27 Falk CT, Rubinstein P. Haplotype relative risk: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987; 51: 227-233.
28. 28 Terwilliger JD, Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Heredity 1992; 42: 337-340.
29. 29 Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene: region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
30. 30 Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R et al. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990; 47: 137-144.
31. 31 McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-770.
32. 32 Kirov G, Murphy K, Arranz M, Jones I, McCandless F, Kunugi H et al. Low activity allele of catechol-O-methyltransferase gene and rapid cycling bipolar disorder. Mol Psychiatry 1998; 3: 342-345.
33. 33 Sham P, Curtis D. An extended transmission disequilibrium test (TDT) for multiallele marker loci. Ann Hum Genet 1995; 59: 323-336.
34. 34 Camp NJ. Genomewide transmission/disequilibrium testing-consideration of the genotypic relative risks at disease loci. Am J Hum Genet 1997; 61: 1424-1430.
35. 35 Curtis D, Sherrington R, Brett P, Holmes DS. Kalsi G, Brynjolfsson J et al. Genetic linkage analysis of manic depression in Iceland. J Royal Soc Med 1993; 86: 500-510.
36. 36 Ewald H, Mors O, Flint T, Eiberg H, Kruse TA. Linkage analysis between manic depressive illness and the doparnine beta-hydroxylase gene. Psychiat Genet 1994; 4: 177-183.
37. 37 De Bruyn A, Souery D, Mendelbaum K. Mendlewicz J, Van Broekhoven C. A linkage study between bipolar disorder and genes involved in dopaminergic and GABAergic neurotransmission. Psychiat Genet 1996; 6: 67-73.
38. 38 Kelsoe JR, Sadovnick AD, Kristhjarnarson H, Bergesch P, Mroczkowski-Parker Z, Drennan M et al. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet 1996; 67: 533-540.
39. 39 Gomez-Casero E, Perez de Castro I, Saiz-Ruiz J, Llinares C, Fernandez-Piqueras J. No association between particular DRD3 and DAT gene polymorphisms and manic-depressive illness in a Spanish sample. Psychiat Genet 1996; 6: 209-212.
40. 40 Waldman ID, Robinson BF, Feigon SA. Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogencity. Genet Epidemiol 1997; 14: 699-704.
41. 41 Souery D, Lipp O. Mahieu B, Mendelhoum K, De Martelaer V, Van Broeckhoven C et al. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1 and TH genes. Am J Med Genet 1996; 67: 551-555.
42. 42 Manki H, Kanba S, Muramatsu T, Higuchi S, Suzuki E, Matsushita S et al. Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders. J Aff Disord 1996; 40: 7-13.
43. 43 BIOMED European Bipolar Collaborative Group. No association between bipolar disorder and allelcs at a functional polymorphism in the COMT gene. Br J Psychiatry 1997; 170: 526-528.
44. 44 Lachman HM, Kelsoe J, Moreno L, Katz S, Papolos DF. Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder. Psychiat Genet 1997; 7: 13-17.
45. 45 Gutiérrez B, Bertranpetit J, Guillamat R, Vallès V, Arranz MJ, Kerwin R et al. Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am J Psychiat 1997; 154: 113-115.
46. 46. Li T, Vallada H, Curtis D, Arranz M, Xu K, Cai G et al. Catechol-O-methyltransforase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics 1997; 7: 349-353.
47. 47 Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 1990; 3: 346-349.
48. 48 Byerley W, Leppert M, O'Connell P, Mellon C, Holik J, Lubbers A et al. D2 dopamine receptor not linked to manic-depression in three families. Psychiat Genet 1990; 1: 55-62.
49. 49 Holmes D. Brynjolfsson J, Brett P, Curtis D, Petursson H, Sherrington R et al. No evidence for a susceptibility locus predisposing to manic depression in the region of the dopamine D2 receptor gene. Br J Psychiatry 1991; 158: 635-641.
50. 50 Mitchell P, Selbie L, Waters B, Donald J, Vivero C, Tully M et al. Exclusion of close linkage of bipolar disorder to the dupamine D1 and D2 receptor gene markers. J Aff Disord 1992; 25: 1-12.
51. 51 Nöthen M, Erdmann J, Körner J, Lanczik M, Fritze J, Fimmers R et al. Lack of association between dopamine D1 and D2 receptor genes and bipolar affective disorder. Am J Psychiatry 1992; 149: 199-201.
52. 52 Ewald H, Mors O, Flint T, Friedrich U, Eiberg H, Kruse TA. Linkage analysis between manic-depressive illness and markers on the long arm of chromosome 11. Am J Med Genet 1995; 60: 386-392.
53. 53 Furlong RA, Coleman TA, Ho L, Rubinsztein JS, Walsh C, Paykel ES et al. No association of a functional polymorphism in the dopamine D2 receptor promoter region with bipolar or unipolar affective disorders. Am J Med Genet 1998; 81: 385-387.
54. 54 Stöber G, Jatzke S, Heils A, Jungkunz G. Knapp M, Mossner R et al. Insertion/deletion variant (-141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. J Neural Transm 1998; 105: 101-109.
55. 55 Mitchell P, Waters B, Vivero C, Le F, Donald J, Tully M et al. Exclusion of close linkage of bipolar disorder to the dopamine D3 receptor gene in nine Australian pedigrees. J Aff Disord 1993; 27: 213-224.
56. 56 Parsian A, Chakraverty S, Todd RD. Possible association between the dopamine D3 receptor gene and bipolar affective disorder. Am J Med Genet 1995; 60: 234-237.
57. 57 Piccardi MP, Severino G, Bocchetta A, Palmas MA, Ruiu S, Del Zompo M. No evidence of association between dopamine D3 receptor gene and bipolar affective disorder. Am J Med Genet 1997; 74: 137-139.
58. 58 Rietschel M, Nöthon MM, Lannfelt L, Sukoloff P, Schwartz JC, Lanczik M et al. A serine to glycine substitution at position 9 in the extracellular N-terminal part nf the dopamine D3 receptor protein: no role in the genetic predisposition to bipolar affective disorder. Psychiatry Res 1993; 46: 253-259.
59. 59 Shaikh S, Ball D, Craddock N, Castle D, Hunt N, Mant R et al. The dopamine D3 receptor gene: no association with bipolar affective disorder. J Med Genet 1993; 30: 308-309.
60. 60 Oruc L, Furac I, Croux C, Jakovljevic M, Kracun I, Folnegovic V et al. Association study between bipolar disorder and candidate genes involved in dopamine-serotonin metabolism and GABAergic neurotransmission: a preliminary report. Psychiat Genet 1996; 6: 213-217.
61. 61 Ewald H, Degn B, Mors O, Kruse TA. Support for the possible locus on chromosome 4p16 for bipolar affective disorder. Mol Psychiatry 1998; 3: 442-448.
62. 62 Abel L, Müller-Myhsok B. Maximum-likelihood expression of the transmission/disequilibrium test and power considerations. Am J Hum Genet 1998; 63: 664-667.